IBDEI0D3 ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17543,0)
 ;;=707.09^^88^939^53
 ;;^UTILITY(U,$J,358.3,17543,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17543,1,4,0)
 ;;=4^707.09
 ;;^UTILITY(U,$J,358.3,17543,1,5,0)
 ;;=5^Pressure Ulcer,Site NEC
 ;;^UTILITY(U,$J,358.3,17543,2)
 ;;=^336841
 ;;^UTILITY(U,$J,358.3,17544,0)
 ;;=V18.0^^88^940^15
 ;;^UTILITY(U,$J,358.3,17544,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17544,1,4,0)
 ;;=4^V18.0
 ;;^UTILITY(U,$J,358.3,17544,1,5,0)
 ;;=5^Family h/o Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,17544,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,17545,0)
 ;;=V16.0^^88^940^7
 ;;^UTILITY(U,$J,358.3,17545,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17545,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,17545,1,5,0)
 ;;=5^Family h/o Cancer of GI Tract
 ;;^UTILITY(U,$J,358.3,17545,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,17546,0)
 ;;=V16.1^^88^940^8
 ;;^UTILITY(U,$J,358.3,17546,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17546,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,17546,1,5,0)
 ;;=5^Family h/o Cancer of Lung
 ;;^UTILITY(U,$J,358.3,17546,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,17547,0)
 ;;=V19.6^^88^940^1
 ;;^UTILITY(U,$J,358.3,17547,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17547,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,17547,1,5,0)
 ;;=5^Family h/o Allergic Disorder
 ;;^UTILITY(U,$J,358.3,17547,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,17548,0)
 ;;=V18.2^^88^940^2
 ;;^UTILITY(U,$J,358.3,17548,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17548,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,17548,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,17548,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,17549,0)
 ;;=V17.5^^88^940^4
 ;;^UTILITY(U,$J,358.3,17549,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17549,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,17549,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,17549,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,17550,0)
 ;;=V17.7^^88^940^3
 ;;^UTILITY(U,$J,358.3,17550,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17550,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,17550,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,17550,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,17551,0)
 ;;=V19.0^^88^940^5
 ;;^UTILITY(U,$J,358.3,17551,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17551,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,17551,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,17551,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,17552,0)
 ;;=V16.3^^88^940^6
 ;;^UTILITY(U,$J,358.3,17552,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17552,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,17552,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,17552,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,17553,0)
 ;;=V16.41^^88^940^9
 ;;^UTILITY(U,$J,358.3,17553,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17553,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,17553,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,17553,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,17554,0)
 ;;=V16.42^^88^940^10
 ;;^UTILITY(U,$J,358.3,17554,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17554,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,17554,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,17554,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,17555,0)
 ;;=V16.43^^88^940^11
 ;;^UTILITY(U,$J,358.3,17555,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17555,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,17555,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,17555,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,17556,0)
 ;;=V19.5^^88^940^13
 ;;^UTILITY(U,$J,358.3,17556,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17556,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,17556,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,17556,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,17557,0)
 ;;=V19.2^^88^940^14
 ;;^UTILITY(U,$J,358.3,17557,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17557,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,17557,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,17557,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,17558,0)
 ;;=V17.3^^88^940^16
 ;;^UTILITY(U,$J,358.3,17558,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17558,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,17558,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,17558,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,17559,0)
 ;;=V16.6^^88^940^17
 ;;^UTILITY(U,$J,358.3,17559,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17559,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,17559,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,17559,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,17560,0)
 ;;=V18.61^^88^940^19
 ;;^UTILITY(U,$J,358.3,17560,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17560,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,17560,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,17560,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,17561,0)
 ;;=V17.0^^88^940^20
 ;;^UTILITY(U,$J,358.3,17561,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17561,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,17561,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,17561,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,17562,0)
 ;;=V19.4^^88^940^21
 ;;^UTILITY(U,$J,358.3,17562,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17562,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,17562,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,17562,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,17563,0)
 ;;=V17.1^^88^940^22
 ;;^UTILITY(U,$J,358.3,17563,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17563,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,17563,1,5,0)
 ;;=5^Family h/o Stroke (CVA)
 ;;^UTILITY(U,$J,358.3,17563,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,17564,0)
 ;;=V16.8^^88^940^12
 ;;^UTILITY(U,$J,358.3,17564,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17564,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,17564,1,5,0)
 ;;=5^Family h/o Cancer,Other Specified
 ;;^UTILITY(U,$J,358.3,17564,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,17565,0)
 ;;=V11.1^^88^940^24
 ;;^UTILITY(U,$J,358.3,17565,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17565,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,17565,1,5,0)
 ;;=5^Hx of Affective Disorder
 ;;^UTILITY(U,$J,358.3,17565,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,17566,0)
 ;;=V15.89^^88^940^46
 ;;^UTILITY(U,$J,358.3,17566,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17566,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,17566,1,5,0)
 ;;=5^Hx of Persian Gulf Region Exposure
 ;;^UTILITY(U,$J,358.3,17566,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,17567,0)
 ;;=V11.3^^88^940^25
 ;;^UTILITY(U,$J,358.3,17567,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17567,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,17567,1,5,0)
 ;;=5^Hx of Alcoholism
 ;;^UTILITY(U,$J,358.3,17567,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,17568,0)
 ;;=V15.07^^88^940^26
 ;;^UTILITY(U,$J,358.3,17568,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17568,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,17568,1,5,0)
 ;;=5^Hx of Allergy to Latex
 ;;^UTILITY(U,$J,358.3,17568,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,17569,0)
 ;;=V13.4^^88^940^27
 ;;^UTILITY(U,$J,358.3,17569,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17569,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,17569,1,5,0)
 ;;=5^Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,17569,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,17570,0)
 ;;=V12.72^^88^940^31
 ;;^UTILITY(U,$J,358.3,17570,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17570,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,17570,1,5,0)
 ;;=5^Hx of Colon Polyps
 ;;^UTILITY(U,$J,358.3,17570,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,17571,0)
 ;;=V12.59^^88^940^30
 ;;^UTILITY(U,$J,358.3,17571,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17571,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,17571,1,5,0)
 ;;=5^Hx of CHF
 ;;^UTILITY(U,$J,358.3,17571,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,17572,0)
 ;;=V45.81^^88^940^29
 ;;^UTILITY(U,$J,358.3,17572,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17572,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,17572,1,5,0)
 ;;=5^Hx of CABG
 ;;^UTILITY(U,$J,358.3,17572,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,17573,0)
 ;;=V15.84^^88^940^28
 ;;^UTILITY(U,$J,358.3,17573,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17573,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,17573,1,5,0)
 ;;=5^Hx of Asbestos Exposure
 ;;^UTILITY(U,$J,358.3,17573,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,17574,0)
 ;;=V15.85^^88^940^47
 ;;^UTILITY(U,$J,358.3,17574,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17574,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,17574,1,5,0)
 ;;=5^Hx of Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,17574,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,17575,0)
 ;;=V10.72^^88^940^34
 ;;^UTILITY(U,$J,358.3,17575,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17575,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,17575,1,5,0)
 ;;=5^Hx of Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,17575,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,17576,0)
 ;;=V15.3^^88^940^35
 ;;^UTILITY(U,$J,358.3,17576,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17576,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,17576,1,5,0)
 ;;=5^Hx of Irradiation
 ;;^UTILITY(U,$J,358.3,17576,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,17577,0)
 ;;=V10.61^^88^940^37
 ;;^UTILITY(U,$J,358.3,17577,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17577,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,17577,1,5,0)
 ;;=5^Hx of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,17577,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,17578,0)
 ;;=V12.03^^88^940^39
 ;;^UTILITY(U,$J,358.3,17578,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17578,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,17578,1,5,0)
 ;;=5^Hx of Malaria
 ;;^UTILITY(U,$J,358.3,17578,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,17579,0)
 ;;=V10.82^^88^940^40
 ;;^UTILITY(U,$J,358.3,17579,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17579,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,17579,1,5,0)
 ;;=5^Hx of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,17579,2)
 ;;=Hx of Malignant Melanoma^295240
